Boundless Bio, Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.44% | -25.32% | -36.93% | -31.67% | -3.10% |
| Total Depreciation and Amortization | 19.84% | 11.49% | 11.34% | 10.97% | 3.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 338.62% | 564.88% | 38.10% | -7.77% | -64.58% |
| Change in Net Operating Assets | -525.56% | 197.43% | -217.17% | 4.87% | -171.15% |
| Cash from Operations | -33.18% | -8.84% | -49.09% | -30.49% | -14.76% |
| Capital Expenditure | -73.88% | -219.87% | -1,075.00% | 3.49% | -587.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.76% | 398.88% | 2.49% | -18.12% | 91.36% |
| Cash from Investing | -88.47% | 386.77% | 0.48% | -18.18% | 89.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 189.74% | -100.00% | 357,592.31% | 90.32% | 11.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 97.56% | -615.20% | -- | -- |
| Cash from Financing | 108.16% | 97.09% | -9.08% | -3,080.65% | -4,054.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -596.97% | 143.49% | -69.34% | -85.78% | 253.70% |